PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING GLUTAMINE SUITABLE FOR TREATING INTESTINAL PATHOLOGIC GUT PERMEABILITY AND WEAKENED IMMUNOFUNCTIONS

摘要

Catabolic, gut-associated pathological processes, including intestinal mucosal and pancreatic atrophy and enhanced gut permeability, impairment of host defences and compromised immune function, can be treated, and recovery from bone marrow transplantation can be promoted by the administration of a therapeutically effective amount of glutamine or an analogue thereof.